SalaryGuide
AboutPricingFor Employers

Marketing jobs

3 marketing jobs

10 days ago

Sr. Associate, Web Strategy & Operations

Amgen

Abilene, TX (Remote)$83K/yr – $112K/yr
athenahealth logo
5 weeks ago

Ad Operations Senior Associate, Direct & Programmatic

athenahealth

Maine, WI (Remote)Full time$66K/yr – $112K/yr
McGarrah Jessee logo
4 months ago

Media Traffic Specialist

McGarrah Jessee

Austin, TX (Remote)Full time$56K/yr – $80K/yr

All marketing roles in the US with a remote work arrangement

Get alerts for this search

All marketing roles in the US with a remote work arrangement

Get alerts for this search

3 jobs

Sr. Associate, Web Strategy & Operations

Amgen

Abilene, TX (Remote)

$83K/yr - $112K/yrIn-houseSenior level6+ years exp.
10 days ago
athenahealth logo

Ad Operations Senior Associate, Direct & Programmatic

athenahealth

Maine, WI (Remote)

$66K/yr - $112K/yrIn-houseFull-timeSenior level3+ years exp.
5 weeks ago
McGarrah Jessee logo

Media Traffic Specialist

McGarrah Jessee

Austin, TX (Remote)

$56K/yr - $80K/yrAgencyFull-timeSenior level5+ years exp.
4 months ago
Amgen

Sr. Associate, Web Strategy & Operations

Abilene, TX (Remote)

$83K/yr – $112K/yrSenior Level6+ years exp

Posted 10 days ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own end-to-end web project delivery by leading scope, plans, budgets and cross-functional collaboration for Amgen’s GCCI website portfolio.

  • Define scope, timelines and deliverables for website launches
  • Track progress, manage risks, and ensure quality across the lifecycle

Job Description

Responsibilities

  • Collaborate with internal clients to define project scope, objectives and deliverables and develop detailed project plans, including scope, timelines, resources and budgets of website launches and updates
  • Support quarterly prioritization of project requests, award agencies and ensure timely execution of high-quality deliverables
  • Ensure effective communication and collaboration between cross-functional teams including copywriters, designers, developers, SEO team, analytics team, and project- and platform owners
  • Monitor project progress and documentation, and take corrective actions as necessary to keep projects on track, including identifying and managing risks, issues and changes throughout the project lifecycle
  • Perform quality assurance checks and hyper care to ensure deliverables meet industry standards, and ongoing strategic and operational support
  • Act as a single Point of Contact (POC) for managing all projects in GCCI WSO for managing assigned web projects
  • Support pilots, rollouts and adoption of new/enhanced capabilities and features for websites and the management and optimization of the global portfolio of websites
  • Support Global Service Center (GSC) Regional Leads with Project Planning and Forecasting, Release Management and Deployment and Creative Support, MAC Services, Quality Assurance and Testing
  • Submit Integrated System Assessment (ISA) across Amgen's global web platforms, which will significantly contribute to Amgen’s regulatory compliance and operational resilience
  • Develop and report on key performance indicators (KPIs) and metrics that gauge the success of websites, analyzing data to provide actionable insights

Requirements

  • Master's degree
  • OR
  • Bachelor’s degree and 4 years of digital or web project management experience
  • Or
  • Associate’s degree and 6 years of digital or web project management experience
  • Or
  • High School diploma/GED and 8 years of digital or web project management experience

Preferred

  • 5+ years of digital project management in a fast-paced, multi-client environment, incl. end-to-end projects across a website lifecycle
  • Proven expertise in managing complex, cross-country and high impact projects. Able to effectively negotiate, manage expectations, and maintain productive relationships with a diverse group of stakeholders across various functions.
  • Strong understanding of agile project management principles and methodologies, with a focus on continuous improvement, preferably SAFe
  • Proficiency in web analytics and Search Engine Optimization (SEO), and User Experience (UX) and User Interface (UI) design principles using tools such as Google Analytics, Google Search Console and Figma
  • Experience with writing detailed documentation
  • Experience with JIRA, ServiceNow, Google Analytics, and Confluence
  • Familiarity with technical specifications, and industry standards and best practices including media file sizes/formats, accessibility standards (WCAG), privacy regulations (GDPR, US Consumer laws) is a plus
  • Knowledge of web development technologies, coding languages and industry best practices, such as HTML and CSS is a plus
  • Experience operating in a regulated business environment and adhering to mandatory compliance requirements (preferably pharma) is a plus
  • Experience prompting ChatGPT and other AI chatbot is a plus

Benefits

  • The expected annual salary range for this role in the U.S. (excluding Puerto Rico) is posted. Actual salary will vary based on several factors including but not limited to, relevant skills, experience, and qualifications.
  • In addition to the base salary, Amgen offers a Total Rewards Plan, based on eligibility, comprising of health and welfare plans for staff and eligible dependents, financial plans with opportunities to save towards retirement or other goals, work/life balance, and career development opportunities that may include:
  • A comprehensive employee benefits package, including a Retirement and Savings Plan with generous company contributions, group medical, dental and vision coverage, life and disability insurance, and flexible spending accounts
  • A discretionary annual bonus program, or for field sales representatives, a sales-based incentive plan
  • Stock-based long-term incentives
  • Award-winning time-off plans
  • Flexible work models where possible. Refer to the Work Location Type in the job posting to see if this applies.

Amgen

4.1 Glassdoor

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes.For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines🔗Global Privacy Statement Directory: www.amgen.com/dpSpecial Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

Founded in 1980
Thousand Oaks, California, USA
37K employees (1,491 in marketing)
www.amgen.com
83% recommend to a friend
89% CEO approval

Traffic Signals

Monthly Visitors
512K
Traffic Source Mix
Search
39.7%
Direct
42.4%
Referral
7.2%
Social
9.4%
Paid
1.2%

Headcount Trend

Current headcount: ~38.1K

Marketing Team

Marketing Team Size
1,259 (3% of company)
Marketing Roles Posted (Last 30 Days)
12

Funding

Total Funding
$28.5B
Last Raise
Post IPO Debt, 3 years ago

Recent News

Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
Mar 21, 2025 • Benzinga
Medicine levy makes the UK un-investable, say pharma leaders
Mar 20, 2025 • PharmiWeb.com
Exosome Therapeutics Market Anticipated to Reach USD 3.36 Billion, at a Notable 10.29% CAGR by 2034
Mar 20, 2025 • EIN Presswire
UK is becoming an 'outlier' for pharma, hitting investment
Mar 20, 2025 • pharmaphorum
Calling UK 'uninvestable,' pharma giants demand revamp of drug cost control policy
Mar 20, 2025 • Fierce Pharma
Nanotechnology-Based Drug Delivery Market Forecasted to Reach USD 20.41 Billion By 2034, at an Impressive 10.72% CAGR
Mar 20, 2025 • EIN Presswire
Niemann-Pick Disease Market Expected to Achieve a Strong 11.62% CAGR, to Reach USD 3.47 Billion by 2034
Mar 20, 2025 • EIN Presswire
The Global Skin Cancer Treatment Market: Trends, Growth, and Future Outlook
Mar 19, 2025 • EIN Presswire
Bispecific Antibody Market Opportunity & Clinical Trials Insight 2030: Bispecific Antibody Drug Sales Forecast to Quadruple by 2030, Driven by Oncology Innovations - ResearchAndMarkets.com
Mar 19, 2025 • Business Wire
Targeted Cancer Therapies Market Projected to Reach USD 20.92 Billion, with a Robust 10.40% CAGR Till 2032
Mar 19, 2025 • EIN Presswire
2 Dividend Stocks to Buy for a Lifetime of Passive Income
Mar 7, 2025 • The Motley Fool
CytomX, Amgen pass on T cell engager; Molecular Partners ends work with Novartis
Mar 7, 2025 • Endpoints News
Cerebral Infarction Treatment Market Analysis Report 2025-2030: Hospital Pharmacies Capture 63.6% of Cerebral Infarction Treatment Distribution in 2024
Mar 7, 2025 • GlobeNewswire News Room
Strategic Innovation Investments by Multinational Drugmakers to Boost India’s Pharmaceutical Sector
Mar 7, 2025 • Thailand Business News
Obesity Care Week 2025 Concludes with a Global Commitment to Care
Mar 7, 2025 • PR Newswire
Gene Therapy Market Global Forecast to 2032: Biopharma Giants Lead Gene Therapy Market Expansion – Latest Developments & Projections
Mar 7, 2025 • GlobeNewswire News Room
Biopharmaceutical Industry Accelerates R&D Investments in Oncology and Cancer Drugs Market | Projected CAGR of 7.5%
Mar 7, 2025 • EIN Presswire
Form 4 AMGEN INC For: Mar 03 Filed by: Santos Esteban
Mar 6, 2025 • StreetInsider.com
Amgen Challenges Novo Nordisk's Ozempic And Eli Lilly's Zepbound As Its Monthly Weight Loss Drug MariTide Enters Two Late-Stage Trials
Mar 6, 2025 • Benzinga
Global Epoetin Alfa Market Outlook 2025-2034: Growth Drivers, Share, And Trends
Mar 6, 2025 • EIN Presswire
Rising Melanoma Cases On The Growth Of The Market: Key Driver Transforming The Imlygic Market In 2025
Mar 6, 2025 • EIN Presswire
Chemotherapy-Induced Anemia Market Size to Reach USD 2,800.2 Million by 2035, Impelled by Rising Focus on Patient-Centered Care
Feb 19, 2025 • BioSpace
Biotechnology Market Size & Share | Growth Analysis 2035
Feb 14, 2025 • PharmiWeb.com
AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
Feb 14, 2025 • Morningstar, Inc.
Amgen Insider Sold Shares Worth $2,585,644, According to a Recent SEC Filing
Feb 14, 2025 • MarketScreener
AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
Feb 14, 2025 • MarketScreener
Amgen ends Ideaya cancer combination trial after partner unveils rival molecule
Feb 13, 2025 • Fierce Biotech
Uplizna Market Report 2025: Size, Trends, and Growth Insights for Global Expansion
Feb 11, 2025 • EIN Presswire
Unveiling the Enbrel Global Market Report 2025: Exponential Growth Expected With A CAGR Of 5.6%
Feb 11, 2025 • EIN Presswire
Global Neutropenia Market: Trends, Growth, and Future Prospects
Feb 11, 2025 • EIN Presswire
The Xgeva Global Market Report 2025: Insights Into Current Scenario And Future Projections, Covering In-depth Analysis
Feb 10, 2025 • EIN Presswire
Peptide Synthesis Market to Reach USD 1.12 Billion by 2031, Driven by Advancements in Drug Development and Rising Demand for Therapeutics: - Market Research Intellect
Dec 10, 2024 • PR Newswire
Amgen (AMGN) Raises Quarterly Dividend 5.8% to $2.38; 3.5% Yield
Dec 10, 2024 • StreetInsider.com
Digital Biomarkers Market CAGR of 34.1% size, share and major trends 2024-2031 | AliveCor Inc., Altoida Inc., Amgen Inc.
Dec 10, 2024 • EIN Presswire
AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND
Dec 10, 2024 • PR Newswire
Acute Myocardial Infarction Market Poised for Remarkable Growth from the Forecast Period 2024-2034 | DelveInsight
Dec 5, 2024 • EIN Presswire
Amgen rolls out $1B investment to build new drug substance plant in NC's biopharma hotbed
Dec 5, 2024 • Fierce Pharma
Amgen to spend $1B on second NC manufacturing plant
Dec 5, 2024 • Seeking Alpha
AMGEN TO PRESENT AT CITI’S 2024 GLOBAL HEALTHCARE CONFERENCE
Dec 3, 2024 • BioSpace
AMGEN TO PRESENT AT CITI'S 2024 GLOBAL HEALTHCARE CONFERENCE
Dec 2, 2024 • PR Newswire
This Stock Just Dropped by 12% in 1 Day: Should You Buy the Dip?
Dec 2, 2024 • The Motley Fool
AMGEN TO PRESENT AT THE 7th ANNUAL EVERCORE HEALTHCONx CONFERENCE
Dec 1, 2024 • BioSpace
Amgen (AMGN) Announces Robust Weight Loss With Maritide In People Living With Obesity Or Overweight At 52 Weeks In A Phase 2 Study
Nov 26, 2024 • StreetInsider.com
Weight loss drugmakers in spotlight as White House proposes coverage
Nov 26, 2024 • thefly.com
S&P 500, Nasdaq open higher as investors assess Trump's tariff threats
Nov 26, 2024 • Investing.com
‘Bulls Disappointed’ as Amgen’s MariTide Demonstrates 20% Weight Loss
Nov 26, 2024 • BioSpace
Amgen’s once-a-month obesity shot shows 20% weight loss after a year
Nov 26, 2024 • Endpoints News
No plateau: Street level-sets obesity on Amgen Maritide phase II
Nov 26, 2024 • BioWorld Financial Watch
AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT
Nov 20, 2024 • PR Newswire
ETF of the week: Focus on the American old guard
Nov 20, 2024 • MarketScreener
Amgen Names Howard Chang as Chief Scientific Officer
Nov 20, 2024 • MarketScreener
Specialty Pharmaceuticals Research Report: Increased Reimbursement Through Medical and Pharmacy Benefits Driving the Market, Reaching $965 Billion by 2030
Nov 20, 2024 • GlobeNewswire News Room
AMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024
Nov 14, 2024 • PR Newswire
Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?
Nov 13, 2024 • Investor's Business Daily
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Nov 8, 2024 • PR Newswire
Tezspire Shows Promise in Reducing Nasal Polyp Symptoms in Phase III Trial for Chronic Rhinosinusitis
Nov 8, 2024 • EuropaWire
AMGEN TO PRESENT AT THE 2024 UBS GLOBAL HEALTHCARE CONFERENCE
Nov 8, 2024 • PR Newswire
Neutropenia Treatment Market to hit USD 20.8 billion by 2032, says Global Market Insights Inc.
Nov 4, 2024 • GlobeNewswire News Room
Stock Market Retreats Before Election Day; Microsoft, Apple, Amazon, Google, Meta In Focus: Weekly Review
Nov 1, 2024 • Investor's Business Daily
Wearable Injectors: Market Trends and Industry Opportunities (2024-2030) with Strategic Analysis of 43 Major Players - Innovations in Micro-Needle and Patch-based Wearable Injectors Propel Growth
Nov 1, 2024 • GlobeNewswire News Room
2024 Research: Pediatric Drugs Market Poised for Robust Growth, Projected at 4.79% CAGR Through 2030
Nov 1, 2024 • GlobeNewswire News Room
‘Imitation is best form of flattery’: Regeneron CEO comments on Amgen’s Eylea biosimilar
Oct 31, 2024 • Endpoints News
AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
Oct 30, 2024 • PR Newswire
Legal win leads Amgen to at-risk launch of Eylea biosimilar
Oct 24, 2024 • pharmaphorum
Amgen put volume heavy and directionally bearish
Oct 23, 2024 • thefly.com
IPG Mediabrands Wins Amgen U.S. Media Review
Oct 23, 2024 • MediaPost.com
Amgen pledges to launch Eylea biosim after legal win—but Regeneron stresses the fight's not over yet
Oct 23, 2024 • FiercePharma
Family Heart Foundation, Amgen team up for ‘Cholesterol Connect’ campaign
Oct 1, 2024 • FiercePharma
Federman & Sherwood Investigates Amgen, Inc. for Data Breach
Sep 27, 2024 • Business Wire
RBC Capital Reiterates Outperform on Amgen, M...
Sep 26, 2024 • Benzinga
Morgan Stanley backs Overweight on Regeneron after Amgen temporarily enjoined
Sep 25, 2024 • thefly.com
Japan approval for Amgen eye drug Tepezza
Sep 25, 2024 • The Pharma Letter
Amgen disclosed 'underwhelming' rocatinlimab data, says Leerink
Sep 25, 2024 • thefly.com
With success in myasthenia gravis trial, Amgen's Uplizna looks set up to add new indication
Sep 25, 2024 • FiercePharma
Stocks in motion: Flutter and Duolingo rise, while Amgen falls
Sep 25, 2024 • MarketScreener
Amgen (NASDAQ:AMGN) shareholders have earned a 15% CAGR over the last five years
Sep 25, 2024 • Yahoo Finance
Street View: Amgen's mixed data on two drugs fans competition concerns
Sep 25, 2024 • TradingView
Amgen presents new data showcasing IMDELLTRATM
Sep 9, 2024 • thefly.com
"A Million Discoveries: How the Amgen Biotech Experience Shapes Future Innovators"
Sep 9, 2024 • Canadian News Wire
#ESMO24 roundup: New data on Amgen’s PRMT5 inhibitor seem lackluster, and Jazz’s HER2 antibody
Sep 9, 2024 • Endpoints News
Russell Abberley, Amgen UK & Ireland, steps up as Acting...
Sep 4, 2024 • PharmiWeb.com
J&J’s human resources leader to retire; Amgen becomes the newest pharma with a top AI exec
Aug 30, 2024 • sdbn.org
BioMarin revamps leadership with ex-Roche, Amgen execs
Aug 22, 2024 • pharmaphorum
Fierce Pharma Asia—Merck-Curon bispecific deal; Legend's path forward; Missing adverse events in Amgen FDA filing
Aug 16, 2024 • FiercePharma
Amgen sues Samsung biotech unit over bone drug copies
Aug 13, 2024 • TradingView
Merck pays $700M for bispecific, spying autoimmune opening and chance to challenge Amgen in cancer
Aug 9, 2024 • FierceBiotech
Are Wall Street Analysts Bullish on Amgen Stock?
Aug 9, 2024 • TradingView
Amgen to open new tech and innovation centre in Hyderabad by 2024-end
Aug 9, 2024 • Times of India
Amgen announces plans for new site in India to strengthen AI, data and life sciences
Aug 9, 2024 • Endpoints News
Amgen: annual targets tightened
Aug 7, 2024 • MarketScreener
Amgen's marketing efforts help boost Tepezza sales
Aug 7, 2024 • FiercePharma
Amgen price target raised by $5 at BofA, here's why
Aug 7, 2024 • thefly.com
Why Amgen Stock Is Down Today Despite Solid Q2 Results
Aug 7, 2024 • The Motley Fool
ANALYST RECOMMENDATIONS : Amgen, Fortinet, Moderna, Airbnb, BP...
Aug 7, 2024 • MarketScreener
Amgen shelves early-stage bispecific T cell engager
Jul 9, 2024 • Endpoints News
In boost to Amgen, analysts predict osteoporosis market share shift
Jun 28, 2024 • FiercePharma
Can Amgen Stock Keep Trouncing the S&P 500?
Jun 27, 2024 • The Motley Fool
Amgen calls Colorado's price controls on Enbrel 'unconstitutional'
Jun 25, 2024 • Endpoints News
Where Will Amgen Be in 5 Years?
Jun 20, 2024 • The Motley Fool
Amgen says FDA approves BLINCYTO
Jun 14, 2024 • thefly.com